Gastrointestinal transit of an enteric‐coated delayed‐release 5‐aminosalicylic acid tablet
- 1 June 1987
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 1 (3) , 209-216
- https://doi.org/10.1111/j.1365-2036.1987.tb00620.x
Abstract
SUMMARY: Gastrointestinal transit of an enteric‐coated, delayed‐release 5‐aminosalicylic acid tablet radiolabelled with indium‐111 has been monitored in a preliminary study with eight healthy subjects using gamma scintigraphy. Gastric emptying of the tablet was delayed by the presence of food in the stomach. Disintegration occurred about 5 hours after the tablet left the stomach. There was close agreement between the tablet disintegration times and the initial detection of drug in the blood. The site of disintegration could be established in most instances; approximately 80% of the doses resulted in drug dispersion within the ascending colon. The coated tablets provide an effective means of drug delivery to the proximal colon.Keywords
This publication has 17 references indexed in Scilit:
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986
- Enema volume and spreadingInternational Journal of Pharmaceutics, 1986
- Whole-bowel transit in patients with the irritable bowel syndromeEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Drug delivery to the proximal colonJournal of Pharmacy and Pharmacology, 1985
- Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.Gut, 1985
- The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet)International Journal of Pharmaceutics, 1984
- SulfasalazineDigestive Diseases and Sciences, 1983
- Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.BMJ, 1983
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980